当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析

晨光生物

(300138)

  

流通市值:42.98亿  总市值:52.13亿
流通股本:3.98亿   总股本:4.83亿

晨光生物(300138)财务分析

净利润 + 每股收益
Created with Highcharts 9.1.003-3112-3109-3006-3000.40.81.20.10.150.20.25
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.11亿元,每股收益0.23元。

股东权益 + 未分配利润
Created with Highcharts 9.1.003-3112-3109-3006-30012243618192021
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益326506.94万元,未分配利润200155.08万元。

总资产 + 负债
Created with Highcharts 9.1.003-3112-3109-3006-3004080120406080100
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1029742.90万元,负债703235.96万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入1,716,472,687.326,994,192,786.235,225,428,968.083,490,929,927.87
营业总成本1,605,425,014.26,868,044,529.725,127,064,914.933,408,448,437.38
营业利润129,813,643.12106,035,576.7160,260,728.27107,811,275.7
利润总额131,283,325.59106,945,324.7174,352,639.96114,093,936.52
净利润111,187,387.9477,957,113.4945,240,156.7893,790,702.64
其他综合收益-807,209.723,336,226.69-6,507,503.312,758,363.21
综合收益总额110,380,178.2281,293,340.1838,732,653.4796,549,065.85
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计8,093,880,839.236,808,992,375.285,565,427,092.556,231,560,503.32
非流动资产合计2,203,548,131.832,213,528,285.322,184,311,145.622,194,128,124.77
资产总计10,297,428,971.069,022,520,660.67,749,738,238.178,425,688,628.09
流动负债合计5,762,603,349.894,596,089,600.873,118,704,931.423,495,510,595
非流动负债合计1,269,756,264.051,271,741,880.821,522,286,736.571,668,315,876.68
负债合计7,032,359,613.945,867,831,481.694,640,991,667.995,163,826,471.68
归属于母公司股东权益合计3,218,162,338.763,109,489,222.53,065,164,116.023,206,957,892.33
股东权益合计3,265,069,357.123,154,689,178.913,108,746,570.183,261,862,156.41
负债和股东权益合计10,297,428,971.069,022,520,660.67,749,738,238.178,425,688,628.09
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计1,918,596,958.417,878,741,829.315,316,694,895.193,504,622,035.95
经营活动现金流出小计1,388,152,550.448,101,556,789.283,713,508,286.092,471,538,007.05
经营活动产生的现金流量净额530,444,407.97-222,814,959.971,603,186,609.11,033,084,028.9
投资活动现金流入小计1,098,489,002.421,060,378,235.151,166,862,948.64901,618,239.22
投资活动现金流出小计2,575,097,320.261,501,333,221.32951,658,165.1631,570,050.99
投资活动产生的现金流量净额-1,476,608,317.84-440,954,986.17215,204,783.54270,048,188.23
筹资活动现金流入小计1,505,278,154.265,783,439,209.463,668,038,020.22,887,838,020.2
筹资活动现金流出小计335,287,014.635,679,638,840.944,239,603,024.863,030,044,739.31
筹资活动产生的现金流量净额1,169,991,139.63103,800,368.52-571,565,004.66-142,206,719.11
汇率变动对现金及现金等价物的影响-2,338,013.84-10,493,145.08-6,716,726.56-4,916,168.61
现金及现金等价物净增加额221,489,215.92-570,462,722.71,240,109,661.421,156,009,329.41
期末现金及现金等价物余额736,291,455.94514,802,240.022,325,374,624.142,241,274,292.13
最新报告期:2025-04-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
方正证券王泽华0.760.951.172025-04-28
中邮证券王琦0.710.941.102025-04-14
浙商证券钟烨晨0.630.720.832025-04-10
华鑫证券张倩,孙山山0.730.941.072025-04-09
方正证券王泽华0.760.951.182025-04-08
TOP↑